科兴制药: 内幕信息知情人登记管理制度

Core Points - The document outlines the insider information management system of Sinovac Biotech Ltd, aiming to ensure fair information disclosure and prevent insider trading [1][2][3] - The board of directors is responsible for managing insider information and ensuring the accuracy and completeness of insider information registries [2][3] - Insider information is defined as any undisclosed information that could significantly impact the company's operations, finances, or stock prices [1][2] Insider Information and Management - Insider information includes significant changes in business strategy, major investments, important contracts, and any events that could lead to substantial financial losses [1][2] - The company must maintain a registry of individuals who have access to insider information, including their roles and the nature of the information they possess [3][4] - All parties involved in the management of insider information must ensure confidentiality and are prohibited from trading based on undisclosed information [6][7] Responsibilities and Compliance - The company is required to report insider information registries and significant event memorandums to regulatory authorities within five trading days after public disclosure [6][7] - Individuals with insider information must sign confidentiality agreements and are prohibited from disclosing or trading based on that information until it is publicly available [6][9] - Violations of the insider information management system can result in disciplinary actions, including termination and legal consequences [7][8]